QQQ   284.21 (+0.01%)
AAPL   115.61 (-1.08%)
MSFT   214.52 (-0.13%)
FB   277.92 (-0.29%)
GOOGL   1,605.00 (+1.20%)
AMZN   3,169.79 (-0.48%)
TSLA   425.86 (+0.76%)
NVDA   533.45 (-1.39%)
BABA   306.36 (-0.52%)
CGC   20.27 (+4.00%)
GE   7.73 (+5.60%)
MU   54.40 (+2.04%)
AMD   79.47 (+0.34%)
T   28.28 (+5.84%)
F   8.19 (+4.33%)
ACB   4.83 (-0.41%)
GILD   60.69 (+0.80%)
NFLX   485.65 (-0.70%)
BA   169.16 (+3.23%)
NIO   27.40 (-1.65%)
BAC   24.85 (+3.33%)
QQQ   284.21 (+0.01%)
AAPL   115.61 (-1.08%)
MSFT   214.52 (-0.13%)
FB   277.92 (-0.29%)
GOOGL   1,605.00 (+1.20%)
AMZN   3,169.79 (-0.48%)
TSLA   425.86 (+0.76%)
NVDA   533.45 (-1.39%)
BABA   306.36 (-0.52%)
CGC   20.27 (+4.00%)
GE   7.73 (+5.60%)
MU   54.40 (+2.04%)
AMD   79.47 (+0.34%)
T   28.28 (+5.84%)
F   8.19 (+4.33%)
ACB   4.83 (-0.41%)
GILD   60.69 (+0.80%)
NFLX   485.65 (-0.70%)
BA   169.16 (+3.23%)
NIO   27.40 (-1.65%)
BAC   24.85 (+3.33%)
QQQ   284.21 (+0.01%)
AAPL   115.61 (-1.08%)
MSFT   214.52 (-0.13%)
FB   277.92 (-0.29%)
GOOGL   1,605.00 (+1.20%)
AMZN   3,169.79 (-0.48%)
TSLA   425.86 (+0.76%)
NVDA   533.45 (-1.39%)
BABA   306.36 (-0.52%)
CGC   20.27 (+4.00%)
GE   7.73 (+5.60%)
MU   54.40 (+2.04%)
AMD   79.47 (+0.34%)
T   28.28 (+5.84%)
F   8.19 (+4.33%)
ACB   4.83 (-0.41%)
GILD   60.69 (+0.80%)
NFLX   485.65 (-0.70%)
BA   169.16 (+3.23%)
NIO   27.40 (-1.65%)
BAC   24.85 (+3.33%)
QQQ   284.21 (+0.01%)
AAPL   115.61 (-1.08%)
MSFT   214.52 (-0.13%)
FB   277.92 (-0.29%)
GOOGL   1,605.00 (+1.20%)
AMZN   3,169.79 (-0.48%)
TSLA   425.86 (+0.76%)
NVDA   533.45 (-1.39%)
BABA   306.36 (-0.52%)
CGC   20.27 (+4.00%)
GE   7.73 (+5.60%)
MU   54.40 (+2.04%)
AMD   79.47 (+0.34%)
T   28.28 (+5.84%)
F   8.19 (+4.33%)
ACB   4.83 (-0.41%)
GILD   60.69 (+0.80%)
NFLX   485.65 (-0.70%)
BA   169.16 (+3.23%)
NIO   27.40 (-1.65%)
BAC   24.85 (+3.33%)
Log in
OTCMKTS:AFFY

Affymax Stock Forecast, Price & News

$0.19
-0.02 (-9.76 %)
(As of 10/21/2020 12:00 AM ET)
Add
Compare
Today's Range
$0.19
Now: $0.19▼
$0.21
50-Day Range
$0.07
MA: $0.15▼
$0.23
52-Week Range
$0.01
Now: $0.19▼
$0.26
Volume155,827 shs
Average Volume133,055 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
Beta2.61
Affymax, Inc. does not have significant operations. Previously, it was developing drugs to enhance the treatment of serious and often life-threatening conditions in the United States. The company was founded in 2001 and is based in New York, New York.
Read More
Affymax logo

Beat the Market (BTM) Rank™

Analyst Opinion: 0.0Community Rank: 3.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank™

0.60 out of 5 stars

Industry, Sector and Symbol

Stock Exchange OTCMKTS
Industry Pharmaceutical preparations
Sub-IndustryBiotechnology
SectorMedical
Current SymbolOTCMKTS:AFFY
Previous Symbol
CUSIP00826A10
CIK1158223
Webwww.affymax.com
Phone650-812-8700
Employees2

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / Cash FlowN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

Outstanding SharesN/A
Market CapN/A
Next Earnings DateN/A
OptionableNot Optionable
$0.19
-0.02 (-9.76 %)
(As of 10/21/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive AFFY News and Ratings via Email

Sign-up to receive the latest news and ratings for AFFY and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Affymax (OTCMKTS:AFFY) Frequently Asked Questions

How has Affymax's stock price been impacted by Coronavirus?

Affymax's stock was trading at $0.0386 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, AFFY shares have increased by 379.3% and is now trading at $0.1850.
View which stocks have been most impacted by COVID-19.

Are investors shorting Affymax?

Affymax saw a increase in short interest in September. As of September 30th, there was short interest totaling 182,000 shares, an increase of 188.0% from the September 15th total of 63,200 shares. Based on an average trading volume of 190,100 shares, the days-to-cover ratio is currently 1.0 days.
View Affymax's Short Interest.

Who are some of Affymax's key competitors?

Some companies that are related to Affymax include Amgen (AMGN), Celgene (CELG), Gilead Sciences (GILD), Regeneron Pharmaceuticals (REGN), Vertex Pharmaceuticals (VRTX), Biogen (BIIB), Seattle Genetics (SGEN), Alexion Pharmaceuticals (ALXN), Immunomedics (IMMU), Incyte (INCY), Alnylam Pharmaceuticals (ALNY), Exact Sciences (EXAS), BioMarin Pharmaceutical (BMRN), Repligen (RGEN) and Neurocrine Biosciences (NBIX).
View all competitors.

What other stocks do shareholders of Affymax own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Affymax investors own include Goldrock Mines (GRM), Molycorp (MCPIQ), Bank of America (BAC), The Boeing (BA), American Express (AXP), Aurinia Pharmaceuticals (AUPH), Actinium Pharmaceuticals (ATNM), Advanced Micro Devices (AMD), Alnylam Pharmaceuticals (ALNY) and Achaogen (AKAO).

Who are Affymax's key executives?

Affymax's management team includes the following people:
  • Mr. Mark G. Thompson, CFO & Sec. (Age 58, Pay $97.49k)
  • Mr. Jonathan M. Couchman, CEO, Pres & Director (Age 50)
  • Dr. Tracy J. Dunn Ph.D., J.D., VP of Intellectual Property & Legal Affairs (Age 57)

What is Affymax's stock symbol?

Affymax trades on the OTCMKTS under the ticker symbol "AFFY."

How do I buy shares of Affymax?

Shares of AFFY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Affymax's stock price today?

One share of AFFY stock can currently be purchased for approximately $0.19.

What is Affymax's official website?

The official website for Affymax is www.affymax.com.

How can I contact Affymax?

Affymax's mailing address is 19200 STEVENS CREEK BOULEVARD SUITE 240, CUPERTINO CA, 95014. The biopharmaceutical company can be reached via phone at 650-812-8700 or via email at [email protected]

This page was last updated on 10/22/2020 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.